Vijayalakshmi Venkatesan
Overview
Explore the profile of Vijayalakshmi Venkatesan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pragasam S, Venkatesan V
Cartilage
. 2020 Dec;
13(1_suppl):1598S-1609S.
PMID: 33327733
Objective: The present study aims to assess for temporal changes in tibial subchondral bone and cartilage in WNIN/Gr-Ob rats (portraying obesity, insulin resistance, dyslipidemia, impaired glucose tolerance, hypertension) in comparison...
12.
Bhanothu V, Venkatesan V
Arch Microbiol
. 2019 Feb;
201(3):267-281.
PMID: 30788519
This review mainly summarizes disease, immune-pathology and the clinical usefulness, advances, potential applications and limitations of new, cutting-edge technology (MG/MP-PCR and/or ARMS-MG/MP-PCR) in the detection of female genital tuberculosis (FGTB)...
13.
Singh H, Pragasam S, Venkatesan V
Endocr Metab Immune Disord Drug Targets
. 2018 Dec;
19(4):481-489.
PMID: 30499422
Background: Metabolic syndrome is a cluster of medical conditions that synergistically increase the risk of heart diseases and diabetes. The current treatment strategy for metabolic syndrome focuses on treating its...
14.
Singh H, Venkatesan V
Curr Drug Targets
. 2018 Jun;
19(14):1672-1682.
PMID: 29929463
Obesity is a prominent risk factor for type 2 diabetes. Management of type 2 diabetes requires weight management in addition to glycemic parameters. For obese type 2 diabetes patients, metformin,...
15.
Islam M, Venkatesan V
Acta Pol Pharm
. 2018 Apr;
73(4):827-834.
PMID: 29648707
Animal models are very common in diabetes research when rodents are mostly used in this regard. Although a number of animal models of type 1 and type 2 diabetes (T2D)...
16.
Kasulanati S, Venkatesan V
Med Hypotheses
. 2018 Feb;
111:24-26.
PMID: 29406990
Innumerable studies have been carried out by people to trace out those elements, find out the mechanisms that are vital to the maintenance of stemness. Amongst them, the one which...
17.
Thipparapu G, Ajumeera R, Venkatesan V
In Silico Pharmacol
. 2017 Nov;
5:10.
PMID: 29085767
Dihydropyrimidine derivatives possess many biological activities due to presence of pyrimidine ring structure in various nucleic acids, vitamins, coenzymes, uric acid and their derivatives. They have possessed broad spectrum actions...
18.
Chairmandurai A, Kanappa S, Vadrevu K, Putcha U, Venkatesan V
Gastroenterology Res
. 2016 Dec;
3(3):125-133.
PMID: 27942290
Background: To study the effect (s) of recombinant human Epidermal Growth Factor (rhEGF) on naproxen induced gastric ulcer in Wistar NIN rats. Methods: Male Wistar NIN rats were randomly divided...
19.
Singh H, Venkatesan V
Endocr Metab Immune Disord Drug Targets
. 2016 Jul;
16(2):89-98.
PMID: 27468767
Inadequate functional beta cell mass seems to be the primary cause of type 2 diabetes. Increased oxidative stress and inflammation are the leading causes of betacell death. Preservation of functional...
20.
Singh H, Parthasarathy V, Farouk M, Venkatesan V
Med Hypotheses
. 2015 Nov;
86:97-9.
PMID: 26549352
Obesity is associated with insulin resistance and type 2 diabetes. Fortunately most obese, insulin-resistant individuals do not develop type 2 diabetes as they can overcome reduced efficiency of insulin action...